Trending...
- IN the Spirit" Spoken Word Documentary Set to Captivate Audiences Worldwide in Summer 2025** - 205
- Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support - 112
- Red Willow Art Building New Artist Models For the Future Art Market
FAYETTEVILLE, Ark. - Californer -- Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China. These patents strengthen Lineus Medical's intellectual property portfolio as the company continues expanding into major healthcare markets worldwide. They also mark a key milestone toward obtaining regulatory clearances and establishing distribution partnerships in these regions.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The Californer
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The Californer
- Club Offers Released on May 18, 2025
- Clarifying the Lineage of Blacks, African-Americans and the American Slave Nation
- Live Good Relaunches "Be The Generation" Initiative to Empower Student Leadership Amid Cuts to Public Health and Education
- Veteran-Turned-Podcast Host Lee Jones Inspires Audiences With Powerful Conversations on Resilience
- From Platinum Plan To Platinum Jubilee: Gangsta Rap Powers Global Healing Movement
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
Source: Lineus Medical
0 Comments
Latest on The Californer
- Boys & Girls Clubs of Silicon Valley expands with Contra Costa merger
- City of Long Beach Facilities and Services Schedule for Memorial Day Holiday
- Host Your Next Retreat in Costa Rica: Tamarindo Bay Boutique Hotel & Studios Offers the Ideal Setting in Playa Tamarindo, Costa Rica
- California invests $1.7 billion to improve safety, resiliency of highways – including millions for highways damaged by LA fires
- Koplon Implant & Family Dentistry Receives National Recognition as One of the Best Dental Implant Practices in the U.S
- San Antonio Buyer Secures 2.375% Mortgage in 2025-Broker Reveals the Mistake Costing Buyers Thousands
- Perpetua Resources Corp. (PPTA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Heritage at South Brunswick Grand Opening Success!
- ICYMI: Governor Newsom reassures international partners that Trump's tariffs don't represent California
- Office of Youth Development Announces Youth Power PB (Participatory Budgeting) Long Beach 2025 Awardees
- City of Camarillo Partners With Agromin To Launch Free Compost and Mulch Program
- Michael Baker International Names Fareeha Kibriya Office Executive - Los Angeles and Long Beach
- $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
- LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
- Marc Soucy's Newest Music Series Approaches Its One Year Mark
- Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim
- MGTT Opens New U.S. Sales Office to Strengthen B2B Support for OEM ODM White Noise Sound Machines
- Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities
- Countrywide Fence Rental Expands its Temporary Fence Rental Business in Iowa Area
- Agustina Palma Turns Heads and Defies Protocol at 78th Cannes Film Festival Red Carpet